We conducted a population‐based cohort study using administrative databases to quantify
the association between oral and inhaled corticosteroid use and onset of diabetes mellitus …

BACKGROUND:: Systemic corticosteroids are known to increase diabetes risk, but the
effects of high-dose inhaled corticosteroids are unknown. We assessed whether the use and …

Aims There is evidence that large doses of inhaled corticosteroids lead to an increased risk
of glaucoma, cataracts and other problems associated with oral corticosteroid use. However …

BACKGROUND: Inhaled corticosteroids (ICSs) are widely used in the treatment of
obstructive lung disease. ICSs have been shown to be systemically absorbed. The …

OBJECTIVE To identify if there is a dose-dependent risk of diabetes complications in
patients treated with corticosteroids who have both diabetes and chronic obstructive …

METHODS—A nested case-control study was implemented using The Health Improvement
Network (3), which is a database containing electronic medical records from family practices …

Objective To determine the frequency of prescriptions for short term use of oral
corticosteroids, and adverse events (sepsis, venous thromboembolism, fractures) associated …

Glucocorticoid-induced hyperglycemia is a common problem both in patients who have a
known diagnosis of diabetes mellitus and those with previously unrecognized …

OBJECTIVE Topical corticosteroids (CSs) are commonly used to treat inflammatory skin
conditions including eczema and psoriasis. Although topical CS package inserts describe …

PREVIEW Although glucocorticoid therapy carries a risk of promoting or exacerbating
hyperglycemia, there are currently no established medical guidelines for detecting or …